Drug intelligence / Profile preview

Regenopia

Development stage
Unknown
Lead developer
S-Lab
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Regenopia is a preservative-free ophthalmic solution formulated as eye drops for the intensive moisturizing and regeneration of the protective barrier of the ocular surface. It is primarily indicated for alleviating symptoms of moderate to severe dry eye syndrome and supporting recovery after ocular surgery. The product contains a combination of active ingredients including sodium hyaluronate (for hydration and tear film stability), trehalose (providing bioprotective and osmoprotective effects), D-panthenol (dexpanthenol, which aids in regeneration and hydration), and in some formulations, fucoidin. These components work synergistically to moisturize the eye surface, enhance comfort, accelerate epithelial healing, stabilize the tear film, and reduce discomfort associated with dry eyes or post-surgical recovery[1][3][4][5]. Clinical studies have shown that use of Regenopia significantly reduces symptom intensity in dry eye disease patients while improving quality of life[3][4].

Brand names
RegenopiaZuma Regenopia
Other names
S-Lab RegenopiaZuma Regenopia
02

Targets

SELL (L-selectin)

Beyond the preview

Go deeper on Regenopia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regenopia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call